Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
US Army
Chinese Patent Office
Johnson and Johnson
Accenture
UBS
Argus Health
Covington
Cantor Fitzgerald

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,508,269

« Back to Dashboard

Summary for Patent: 5,508,269
Title: Aminoglycoside formulation for aerosolization
Abstract:An aminoglycoside formulation for delivery by aerosolization. The concentrated aminoglycoside formulation containing an efficacious amount of aminoglycoside able to inhibit 95-100% of susceptible bacteria. Aminoglycoside formulated in 5 ml solution of a quarter normal saline having pH between 5.5 and 6.5. The method for treatment of endobronchial infections by a produced by a formulation delivered as an aerosol having mass medium average diameter predominantly between 1 to 5 .mu., produced by a jet or ultrasonic nebulizer.
Inventor(s): Smith; Arnold L. (Columbia, MO), Ramsey; Bonnie W. (Seattle, WA), Montgomery; Alan B. (Bellevue, WA)
Assignee: Pathogenesis Corporation (Seattle, WA)
Application Number:08/325,705
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,508,269
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent 5,508,269

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
McKesson
US Department of Justice
Cantor Fitzgerald
Covington
Argus Health
Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.